Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | ABVX | PRAX | ||
| Company | Cytokinetics | Abivax Sa ADR | Praxis Precision Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 78.38 | 125.64 | 335.23 | ||
| High | 79.01 | 129.18 | 340.21 | ||
| Low | 72.15 | 123.45 | 323.30 | ||
| Latest | 74.84 | 126.54 | 338.07 | ||
| Change | -2.25 | +2.76 | +4.77 | ||
| % Change | -2.92% | +2.23% | +1.43% | ||
| Volume | 4,803,400 | 1,240,100 | 361,000 | ||
| 20-Day Average Volume | 2,660,235 | 918,060 | 400,020 | ||
| Previous Close | 77.09 | 123.78 | 333.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 65.82 | 118.17 | 331.15 | ||
| 20-Day Raw Stochastic | 75.13% | 88.61% | 65.61% | ||
| 20-Day Relative Strength | 64.11 | 56.95 | 55.00 | ||
| Weighted Alpha | +87.46 | +149.83 | +168.24 | ||
| Today's Opinion | 88% Buy | 64% Buy | 100% Buy | ||
| Previous Opinion | 96% Buy | 64% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 8% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.61% since 04/29/26 | +19.11% since 04/29/26 | +4.60% since 04/29/26 | ||
| Low | 59.69 on 04/30/26 | 108.12 on 04/30/26 | 310.01 on 05/01/26 | ||
| High | 80.20 on 05/05/26 | 129.18 on 05/06/26 | 344.99 on 05/05/26 | ||
| 1-Month | |||||
| %Chg | +15.24% since 04/06/26 | +5.92% since 04/06/26 | +9.02% since 04/06/26 | ||
| Low | 58.65 on 04/29/26 | 106.00 on 04/29/26 | 300.57 on 04/07/26 | ||
| High | 80.20 on 05/05/26 | 129.18 on 05/06/26 | 352.78 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | +20.05% since 02/06/26 | +7.54% since 02/06/26 | +5.79% since 02/06/26 | ||
| Low | 58.43 on 03/13/26 | 100.15 on 03/30/26 | 271.95 on 03/30/26 | ||
| High | 80.20 on 05/05/26 | 133.42 on 02/20/26 | 356.00 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +24.11% since 11/06/25 | +21.79% since 11/06/25 | +96.15% since 11/06/25 | ||
| Low | 58.25 on 11/07/25 | 100.15 on 03/30/26 | 159.74 on 11/07/25 | ||
| High | 80.20 on 05/05/26 | 148.83 on 12/24/25 | 356.00 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,577,506 | 9,814,640 | 9,289,734 | ||
| Shares Outstanding, K | 124,238 | 79,291 | 27,872 | ||
| Annual Sales | 88,040,000 | 0 | 0 | ||
| Annual Net Income | -784,960,000 | -380,270,000 | -303,270,000 | ||
| Last Quarter Sales | 17,760,000 | 0 | 0 | ||
| Last Quarter Net Income | -183,030,000 | -90,870,000 | -88,910,000 | ||
| 60-Month Beta | 0.38 | 0.84 | 2.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.67 on 05/05/26 | -1.19 on 03/23/26 | -3.50 on 02/19/26 | ||
| Earnings Date | 05/05/26 | 06/01/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||